I watched the SBS broadcast and commend them on an informative well balanced coverage. While it may not ignite the SP, it has definitely focused very positive attention on this sector. It covered Australian legislative issues and lack of clinical trials but also focused on the Israeli connection where trials have been documented since the 1960's. I must stress we have Israeli board members and Sydney University connections on our board, so it would seem MXC is very well positioned to capitalize on this growth industry. Great result really, lets see what transpires.
Latest Media, page-381
-
- There are more pages in this discussion • 388 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.040(10.3%) |
Mkt cap ! $18.76M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 35.0¢ | $39.73K | 107.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 4697 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| RGT (ASX) Chart |